Strengthening Physician Communication About HPV Vaccines
Launched by UNIVERSITY OF COLORADO, DENVER · May 27, 2015
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria for immunization rate assessment:
- • 1. 9 years of age or older when presenting for care
- • 2. Patients who present for care one year prior to the start of the intervention and up to two years after the start of the intervention
- Exclusion Criteria:
- • 1. Less than 9 years of age when presenting for care
- • 2. Patient is not eligible for HPV immunization
- Provider survey:
- • Providers who are working at participating practices during the two times a cross-sectional survey is administered.
- Parent survey:
- • Parents of adolescents who presented for care within one 1 year prior to the two times a cross-sectional survey is administration.
Trial Officials
Amanda Dempsey, MD, PhD, MPH
Principal Investigator
University of Colorado, Denver
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
